You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CALAN SR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Calan Sr, and when can generic versions of Calan Sr launch?

Calan Sr is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in CALAN SR is verapamil hydrochloride. There are seventeen drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the verapamil hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Calan Sr

A generic version of CALAN SR was approved as verapamil hydrochloride by EXELA PHARMA on March 30th, 1984.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CALAN SR?
  • What are the global sales for CALAN SR?
  • What is Average Wholesale Price for CALAN SR?
Summary for CALAN SR
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 146
Drug Prices: Drug price information for CALAN SR
What excipients (inactive ingredients) are in CALAN SR?CALAN SR excipients list
DailyMed Link:CALAN SR at DailyMed
Drug patent expirations by year for CALAN SR
Drug Prices for CALAN SR

See drug prices for CALAN SR

US Patents and Regulatory Information for CALAN SR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer CALAN SR verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 019152-003 Mar 6, 1991 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer CALAN SR verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 019152-002 Dec 15, 1989 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer CALAN SR verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 019152-001 Dec 16, 1986 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.